Reimagining the future of healthcare

ASHLEY / Huntington’s Disease Community Advocate

Ashley, Huntington’s Disease Community Advocate

Press Releases

Feb 28, 2024
uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
Dec 19, 2023
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
Dec 8, 2023
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635©(4)

See All